Dopo l'orario di chiusura: 11.71

Mineralys Therapeutics Inc (MLYS)

Mineralys Therapeutics Inc Borsa (MLYS) Ultime notizie

Mineralys Therapeutics Inc (MLYS)

Mineralys Therapeutics Inc Borsa (MLYS) Ultime notizie

Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap Up to $11.69 - MarketBeat

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! - Morningstar

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Investors to Learn More About the Investigation - AccessWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc.MLYS - PR Newswire

Mineralys In Hypertension: Upcoming Catalysts And Strong Positioning (NASDAQ:MLYS) - Seeking Alpha

Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! - GlobeNewswire Inc.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Investors to Connect - AccessWire

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! - businesswire.com

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc.(MLYS) and Encourages Stockholders to Learn More About the Investigation - AccessWire

Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc.(MLYS) Investors to Inquire about Securities Investigation - AccessWire

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! - ForexTV.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc.MLYS - Kilgore News Herald

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Mineralys Therapeutics, Inc.(MLYS) And Encourages Investors to Reach Out - AccessWire

MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - ForexTV.com

MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire

MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law - EIN News

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Mineralys Therapeutics, Inc.(MLYS) And Encourages Stockholders to Reach Out - AccessWire

(MLYS) Trading Report - Stock Traders Daily

Mineralys Therapeutics (NASDAQ:MLYS) Trading 3.8% Higher - MarketBeat

Investors in cash trouble should check out Mineralys Therapeutics Inc (MLYS) - SETE News

Mineralys Therapeutics to Speak at Wells Fargo Healthcare Conference - MyChesCo

Mineralys Therapeutics to Participate in the Wells Fargo Healthcare Conference - GlobeNewswire

H.C. Wainwright initates Mineralys Therapeutics Inc (MLYS) rating to a Buy - Knox Daily

Mineralys Therapeutics to Participate in the Wells Fargo Healthcare Conference - Marketscreener.com

Mineralys Therapeutics to Participate in the Wells Fargo Healthcare Conference - StockTitan

Mineralys Therapeutics (NASDAQ:MLYS) Trading 7.5% Higher - MarketBeat

Mineralys Therapeutics (NASDAQ:MLYS) Stock Rating Reaffirmed by HC Wainwright - Defense World

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) to Post Q3 2024 Earnings of ($0.83) Per Share, HC Wainwright Forecasts - MarketBeat

It makes sense and dollars to buy Mineralys Therapeutics Inc (MLYS) stock - SETE News

Q3 2024 Earnings Forecast for Mineralys Therapeutics, Inc. Issued By Lifesci Capital (NASDAQ:MLYS) - Defense World

Q3 2024 Earnings Estimate for Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Issued By HC Wainwright - Defense World

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q2 2024 Earnings Call Transcript - Insider Monkey

Mineralys Therapeutics (NASDAQ:MLYS) Rating Reiterated by HC Wainwright - MarketBeat

Earnings call: Mineralys Therapeutics reports solid Q2 2024 progress By Investing.com - Investing.com Australia

Stock Market Recap: Mineralys Therapeutics Inc (MLYS) Concludes at 9.13, a -22.82 Surge/Decline - The Dwinnex

Mineralys Therapeutics Inc (MLYS) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Mineralys stock keeps Buy rating, PT at Goldman Sachs post Q2 - Investing.com

Mineralys Therapeutics Posts Q2 Financial Results, Updates on Clinical Trials - MyChesCo

Earnings call: Mineralys Therapeutics reports solid Q2 2024 progress By Investing.com - Investing.com Canada

Earnings call: Mineralys Therapeutics reports solid Q2 2024 progress - Investing.com

Mineralys Therapeutics kicks off key program, shares hold buy rating with Stifel - Investing.com Canada

Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap Down to $11.83 - MarketBeat

Mineralys stock keeps Buy rating, PT at Goldman Sachs post Q2 - Investing.com India

Mineralys Therapeutics kicks off key program, shares hold buy rating with Stifel - Investing.com UK

Vanguard Group Inc. Has $12.69 Million Stock Holdings in Mineralys Therapeutics, Inc. (NASDAQ:MLYS) - Defense World

MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q2 2024 - InvestorPlace

Mineralys Therapeutics : Corporate Overview August 2024 - Marketscreener.com

Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online

Mineralys Therapeutics (MLYS) Set to Announce Quarterly Earnings on Tuesday - Defense World

Mineralys Therapeutics to Announce Q2 2024 Financial Results - MSN

Mineralys Therapeutics to Announce Q2 2024 Financial Results - MyChesCo

Mineralys Therapeutics to Announce Second Quarter 2024 - GlobeNewswire

Mineralys Therapeutics (MLYS) Scheduled to Post Earnings on Tuesday - MarketBeat

Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024 - ForexTV.com

Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024 - Marketscreener.com

Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024 - Yahoo Finance

(MLYS) Investment Analysis - Stock Traders Daily

Simile a MLYS